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 Abstract 
 
Rationale: Prospective memory (PM) deficits in recreational drug users have been 
documented in recent years. However the assessment of PM has largely been restricted to self 
report measures that fail to capture the distinction between event based and time based PM. 
The aim of the present study is to address this limitation. 
 
Objectives: Extending our previous research we augmented the range laboratory measures of 
PM by employing the CAMPROMPT test battery to investigate the impact of illicit drug use 
on prospective remembering in a sample of cannabis only, ecstasy/polydrug and non users of 
illicit drugs, separating event and time based PM performance. We also administered 
measures of executive function and retrospective memory in order to establish whether 
ecstasy/polydrug deficits in PM were mediated by group differences in these processes.  
 
Results: Ecstasy/polydrug users performed significantly worse on both event and time based 
prospective memory tasks in comparison to both cannabis only and non user groups. 
Furthermore, it was found that across the whole sample, better retrospective memory and 
executive functioning was associated with superior PM performance. Nevertheless, this 
association did not mediate the drug-related effects that were observed. Consistent with our 
previous study, recreational use of cocaine was linked to PM deficits. 
 
Conclusions: PM deficits have again been found among ecstasy/polydrug users which appear 
to be unrelated to group differences in executive function and retrospective memory. 
However, the possibility that these are attributable to cocaine use cannot be excluded.
 Prospective memory (PM) involves remembering to execute a particular behaviour at 
some future point in time which may be in the short or long term, for example remembering 
to turn off the lights when leaving a room or remembering to attend a meeting, meet a friend 
or pass on a message. Self report measures of this construct have been developed (e.g., 
Crawford et al., 2005; Hannon et al., 1995) and in previous research from our laboratory, Fisk 
and co-workers have demonstrated apparent impairments on these measures among 
ecstasy/polydrug users (Montgomery & Fisk, 2007) and cannabis only users (Fisk & 
Montgomery, 2008). Other researchers have also reported deficits on self report PM measures 
among users of illicit drugs (Heffernan et al., 2001a; 2001b; Rodgers et al., 2001; 2003) and 
studies from our own laboratory and elsewhere have revealed deficits among illicit drug users 
in laboratory measures of PM (Hadjiefthyvoulou et al., in press; Rendell et al., 2007a; 
Rendell et al., 2009).  
Unsurprisingly, given their role in supporting memory functions in general, evidence 
suggests that PM is dependent on medial temporal-hippocampal processes. For example, in a 
clinical group with medial temporal sclerosis, Adda et al. (2008) found that PM performance 
was impaired and that among those with left hemisphere lesions the degree of impairment 
was correlated with that in delayed (7 day) verbal recall on the Rey Auditory Verbal Learning 
Task (RAVLT). Leitz et al. (2009) found that PM performance was significantly correlated 
with episodic memory recall following acute administration of alcohol. In another recent 
study utilising magnetoencephalography, Martin et al. (2007) found that that the hippocampal 
region was activated longer during both retrospective and prospective memory tasks relative 
to a control condition. Interestingly other regions were also differentially implicated, since 
compared to the retrospective and control tasks, the PM task was associated with earlier onset 
of activation in the posterior parietal lobe. In an animal study by Goto and Grace (2008) in 
which rats searched for food rewards in a radial maze, prospective and retrospective memory 
elements of PM were explored. The results suggested that the retrospective aspect although 
requiring hippocampal input also recruits PFC resources before the prospective component 
can be activated. Furthermore the dopaminergic system appeared to differentially support this 
process with the D1 receptor apparently supporting the former aspect and the D2 receptor the 
latter prospective component. Since ecstasy impacts both serotonergic and dopaminergic 
processes, this raises the possibility that disruption of dopaminergic processes might be 
responsible for the PM deficits that have been observed in human drug users. 
Aside from its reliance on medial temporal structures, PM is known to utilise 
prefrontal executive processes including the working memory system. Neuroimaging studies 
have revealed the involvement of the frontopolar cortex (Brodmann area 10) and 
neighbouring prefrontal areas during the performance of PM tasks (Okuda et al., 2007). Other 
research utilising dual task methodology (Marsh & Hicks, 1998) cognitive ageing paradigms 
(McDaniel et al., 1999) and Parkinson’s related deficits (Kliegel et al., 2005) has also linked 
PM functioning to prefrontal lobe capacity.  
It is worthy of note that prospective memory functions may be defined as either event-
based or time-based. For example, some predefined external event may trigger the retrieval of 
the intention to act, or alternatively the trigger may be the elapse of a given period of time.  
There is evidence to suggest that the two classes utilise neural processes that are at least in 
part separable. For example, Burgess et al., (2003) and Gilbert et al., (2005) have shown that 
event-based tasks utilise the frontopolar cortex, including Brodmann area 10 (BA10). Similar 
findings were reported by Fleming et al. (2008) in patients with frontally based traumatic 
brain injury (TBI), particularly in relation to event-based PM. More recently PET scanning 
has revealed that while the left superior frontal gyrus was involved in both types of tasks, 
different areas within this structure were found to be activated. Furthermore, in addition to 
the frontopolar cortex, the time-based tasks also activated more diverse regions including 
anterior medial frontal regions, the right superior frontal gyrus and the anterior cingulate 
(Okuda et al., 2007). Given the clear dependence of PM on medial temporal/hippocampal 
processes and on the PFC, it is also clearly of relevance that ecstasy/polydrug related deficits 
have been observed on tasks supported by these structures, including aspects of executive 
functioning (see Murphy et al., 2009 for a review). It would therefore be of value to 
determine whether or not the drug-related deficits in medial temporal processes and in PFC 
functions are responsible for the ecstasy/polydrug related deficits that have been observed in 
PM. 
While a number of researchers have used self-report measures to investigate PM 
deficits among illicit drug users (Heffernan et al., 2001a; 2001b; Montgomery and Fisk, 
2007; Rodgers et al., 2001; 2003), to date relatively few studies in this area have used 
laboratory tests of prospective memory. McHale and Hunt (2008) administered two simple 
laboratory tests: remembering to press a timer 10 minutes after being instructed to do so and 
remembering to post an envelope back to the experimenter two days after the test session. 
Cannabis users were found to be impaired on both of these measures. A popular recent 
addition to laboratory measures of PM is the ‘virtual week’ paradigm. This PM test is a board 
game completed in the laboratory in which the participant is required to execute previously 
learned tasks at specified points as they progress around the board at specific times or in 
conjunction with specific events. This measure has featured in a number of studies. For 
example, deficits were observed on this measure among currently abstinent ecstasy users 
including those who used infrequently (Rendell et al., 2007a). Long term abstinent 
methamphetamine users were also found to be impaired on the measure relative to a drug 
naive control group (Rendell et al., 2009). Furthermore, impairments were also evident in 
measures of verbal learning and delayed recall (RAVLT), forward and backward digit span, 
and the Hayling sentence completion task (believed to load on the inhibitory executive 
process). The extent of the methamphetamine-related effect in PM was found to covary 
substantially with the degree of impairment on the Hayling task (Rendell et al., 2009). In 
other research utilising the virtual week, Leitz et al. (2009) demonstrated that performance 
was impaired following the acute administration of alcohol. However, in a subsequent study, 
the deficit was eliminated when individuals were instructed simulate the required actions at 
the time of encoding (by imaging the full sensory aspects of the context in which the action 
was to be completed; Paraskevaides et al., 2010). The measure has also been used to 
investigate the basis of PM deficits in individuals with mild cognitive impairment and 
dementia (Thompson et al., 2010), multiple sclerosis (Rendell et al., 2007b) and 
schizophrenia (Henry et al., 2007).  
While the virtual week paradigm has its merits, before the PM element can be 
completed, it is necessary to learn each of the ten particular responses that is paired with 
specific locations on the board and select the appropriate response from among the set of 
available alternatives each time a PM action is triggered. This is made easier by the fact that 
some responses are common to different tasks. However, the test has clearly has an  
associative learning component and Montgomery et al. (2005) have demonstrated that ecstasy 
users are impaired on paired associative learning. Thus it is possible that some of the deficits 
evident on the virtual week might be attributable to this aspect rather than the PM 
components. That said, it is worthy of note that just over half of the virtual week PM sub-
tasks are regular and more repetitive in nature and thus more readily learned. It is the 
remaining more irregular tasks that have a more substantial learning requirement. 
Interestingly ecstasy users performed worse on these irregular virtual week tasks recording 
65% of the level of correct responses achieved by nonusers while for regular tasks the 
percentage was 83% (computed from Table 2; Rendell et al., 2007a). This suggests that 
performance is indeed adversely affected by the learning component. Nonetheless it must be 
acknowledged that there was no statistically significant interaction between user group and 
task type with users demonstrating a significant deficit overall. Thus while group differences 
in learning may partially account for the virtual week results the outcomes obtained are 
nonetheless consistent with an ecstasy-related PM deficit.. 
In our previous study (Hadjiefthyvoulou et al., in press) in order to minimise the 
learning requirement we used a small number of more simple PM tasks, for each of which 
only a single stimulus-response paring needed to be learned. We also used the Rivermead 
Behavioural Memory Test (RBMT; Wilson et al., 1999) battery which includes three separate 
PM tasks. In our study, only one of the three RBMT PM measures produced statistically 
significant ecstasy/polydrug related deficits. However, the RBMT has been criticised as 
lacking the sensitivity to detect memory problems in non clinical populations (Spooner & 
Pachana, 2006). Thus it may be that the test was not appropriate for the university based 
sample of recreational drug users which featured in our previous study.   A more up-to-date 
test battery that is sensitive to individual differences both within clinical and normal 
populations is the Cambridge Prospective Memory Test (CAMPROMPT; Fleming et al., 
2008; Groot et al., 2002; Wilson et al., 2005). The purpose of the present study is to confirm 
and extend our previous findings utilising the more sensitive CAMPROMPT measure. At the 
same time we will take measures of executive functioning and retrospective memory in order 
to establish the extent to which any ecstasy/polydrug deficits in PM that are uncovered are 
mediated by deficits in those memory and executive functions that are known to underpin PM 
processes. This aspect was not addressed in our previous study. A further innovation in the 
present study is the inclusion of a cannabis-only control group (i.e., individuals whose illicit 
drug use is restricted to cannabis). Using self-report measures we (Fisk & Montgomery, 
2008) have previously documented PM deficits among cannabis only users (relative to 
nonusers of illicit drugs). However we have not previously assessed a cannabis-only user 
group on laboratory measures of PM and not in relation to ecstasy/polydrug users. It is 
expected that both illicit drug using groups will perform worse than nonusers of illicit drugs 
on the CAMPROMPT measures. No prediction is made in relation to PM differences 
between the two illicit drug using groups. 
Method 
Design and Analytical Strategy 
 A between participants design was employed with drug using group with three levels 
(ecstasy/polydrug, cannabis-only, and nonusers of illicit drugs) as the independent variable. 
The dependent variables were the CAMPROMPT time and event based PM scores. 
Background variables and the executive and recall measures were also assessed for group 
differences.  
Pearson’s correlation coefficients were calculated between the PM measures and 
respectively the executive and recall measures. Regression analyses were conducted with the 
PM measures as dependent variables. In each regression, those variables that were 
significantly correlated with the PM measures and any background measures yielding 
statistically significant drug-related differences were included as predictors. Since the drug 
use IV had nominal level of measurement it was not possible to include it directly in the 
regression. Following the procedure outlined by Tabachnick and Fidell (2007), group 
differences were incorporated into the regression by constructing two dichotomous variables. 
In the first, ecstasy/polydrug users were coded as ‘1’ and all other persons coded as ‘0’, in the 
second cannabis-only users were coded as ‘1’ with all other persons coded as ‘0’. In this way 
it was possible to establish whether each group accounted for statistically significant unique 
variance while controlling for the effects of the other predictors. 
Participants. 
Twenty-nine ecstasy/polydrug users (12 females), 12 cannabis-only users (7 females), 
and 18 nonusers of illicit drugs (16 females) took part in this investigation (for demographic 
details see Table 1). The gender composition differed significantly between the groups with 
females predominating among the non illicit user group and males among the 
ecstasy/polydrug users, χ2 (N=59, DF=2) = 10.40, p<.01. Participants were recruited via 
direct approach to university students and the snowball technique, i.e., word-of-mouth 
referral (Solowij et al., 1992). All participants were university students attending the 
University of Central Lancashire (UCLAN) or Liverpool John Moores University (LJMU). 
Materials 
A background drug-use questionnaire that has been previously employed by us 
(Montgomery et al., 2005) assessed the history of illicit drug use and estimated the total 
lifetime use, frequency of use, recent consumption, as well the period of abstinence, for each 
drug (e.g. ecstasy, cannabis, amphetamines, cocaine etc). Fluid intelligence was measured via 
Raven’s Progressive matrices (Raven et al., 1998) and a further questionnaire assessed the 
participant’s age and gender, the number of years of education and their current use of 
alcohol and cigarettes.  
Prospective and retrospective memory questionnaire (PRMQ; Crawford et al., 2005). 
The PRMQ provides a self report measure of prospective and retrospective memory slips in 
everyday life. It consists of sixteen items, eight referring to prospective memory failures e.g. 
“Do you decide to do something in a few minutes time and then forget to do it?” and eight 
concerning retrospective failures e.g. “ Do you fail to recognize a place you have visited 
before?”. Participants were asked to specify how often these things happened to them on a 5-
point scale” very often, quite often, sometimes, rarely, never. Ratings were subsequently 
assigned numerical values of 5 (very often) to 1 (never). A total score for each subscale 
(prospective memory and retrospective memory) was also calculated with minimum score of 
8 and maximum score of 40 with higher scores indicative of more memory problems. 
Rey Auditory Verbal Learning Test (RAVLT; based on Rey, 1964). The RAVLT is a 
test developed to evaluate verbal learning and memory. A list (List A) of 15 words was 
presented to the participant orally, with the aid of an audio recording device, for five 
consecutive times. At the end of each trial the participant was asked to recall as many words 
as possible from the list. After the fifth trial, an interference list (List B), also consisting of 15 
words was read to the participant after which she/he was asked to recall as many words as 
possible from the interference list. Immediately following this the participant was again asked 
to recall the words from list A without hearing it again (trial 6). Next after a 20-minute 
interval, the participant was asked to remember the words from list A (trial 7) after which a 
recognition test was administered. For the recognition test a list consisting of the 15 words 
from list A and 15 distracter words was read to the participant and the individual was asked 
to indicate whether the word belonged to list A or not. A number of outcome measures were 
produced, first the total number of words correctly recalled over trials one to five, second a 
measure of proactive interference (number correct on trial one minus number correct on the 
interference list), third retroactive interference (number correct on trial five minus number 
correct on trial six) and fourth, a measure of decay (number correct on trial five minus 
number correct on trial 7). 
Memory compensation questionnaire (MCQ; Dixon, de Frias & Bäckman,2001). The 
MCQ is a 44 item self-report measure assessing the variety and number strategies the 
participant uses to compensate for deficient memory performance. The MCQ is comprised of 
seven subscales: external (e.g. “Do you use shopping lists when you go shopping?”); internal 
(e.g. “Do you take your time to go through and reconstruct an event you want to 
remember?”): time (e.g. “Do you ask people to speak slowly when you want to remember 
what they are saying?”); reliance (e.g. “When you want to remember an important 
appointment do you ask somebody else (for example, spouse or friend) to remind you?”); 
effort (e.g. “Do you put in a lot of effort when you want to remember an important 
conversation with a person?”); success (e.g. “When you want to remember a newspaper 
article is it important to you to remember it perfectly?”); and change (e.g. “Do you use such 
aids for memory as notebooks or putting things in certain places more or less often today 
compared to 5-10 yrs ago?”). Responses for each item are presented on a 5-point scale, with 
higher scores representing more frequent use of the specified compensatory behavior 
(1=never, 5=always) with some items being reversely scored.  
Behavioral Rating Inventory of Executive Function-Adult Version (BRIEF-A) (Roth 
et al., 2005). The BRIEF-A is a 75 item measure of executive function. For each item the 
participant responds on a three point scale: Never, Sometimes and Often. The measure 
provides indicators of nine aspects of executive functions. These map onto two higher level 
indices the Behavioral Regulation Index (BRI) and the Metacognitive Index (MI). The BRI 
refers to the ability of the individual to maintain appropriate regulatory control of their own 
behavior and emotional responses and is comprised of four sub-scales; Inhibit (e.g. “I tap my 
fingers or bounce my legs”), Shift ( e.g. “I have trouble changing from one activity to 
another”), Emotional Control (e.g. “I have angry outbursts”), and Self-Monitor (e.g. “I don't 
notice when I cause others to feel bad or get mad until is too late”). The MI refers to the 
individual’s ability to systematically solve problems through effective planning and 
organization. It relates directly to the ability to engage in active problem solving across a 
variety of contexts and is comprised of five sub-scales; Initiate (e.g. “I need to be reminded to 
begin a task even when I am willing”),Working Memory (“I have trouble concentrating on 
tasks (such a chores, reading or work)”), Plan/Organize (e.g. “I get overwhelmed by large 
tasks”), Task Monitor (e.g. “I make careless errors when completing tasks”), and 
Organization of Materials (e.g. “I am disorganized”). For both the BRI and the MI higher 
scores are indicative of more executive dysfunction. 
The Cambridge Prospective Memory Test (CAMPROMPT) (Wilson et al., 2005). The 
CAMPROMPT is a laboratory measure of prospective memory that consists of a total of six 
prospective memory tasks, three cued by time and three cued by events. Participants were 
asked to work on some distractor tasks such as word-finder puzzles or a general knowledge 
quiz for a twenty minute period while they had to remember to perform the prospective 
memory tasks. The participants were allowed to spontaneously use strategies, such as taking 
notes, to help them remember. Two of the three time based tasks were cued by a countdown 
kitchen timer and the participant had to remind the experimenter not to forget his/her mug or 
keys when there were seven minutes left to the end of the session. In the second task, when 
the timer showed sixteen minutes the examiner asked the participant to remember that “in 
seven minutes time” he/she had to stop whichever task was they were on and change to 
another. The third time based task was cued by a clock. The participant was asked at a 
specific time (e.g. ten past eleven; 5 minutes after the 20 minute session) to remind the 
examiner to ring the reception/garage. For the event based tasks the participant was asked: 1) 
to return a book to the examiner when he/she came to a question about the television program 
‘EastEnders’ during the general knowledge quiz; 2) to return an envelope with “MESSAGE” 
written on it when he/she was reminded that there were five minutes left in the test; and 
finally, 3) when the examiner informed him/her that the session was over, to remind the 
examiner to pick up five objects that had been hidden at the beginning of the session. Six 
points were awarded for each subtask that was successfully completed, unaided. If the task 
was completed after a single general prompt from the experimenter then 4 points were 
awarded. Alternatively participants were awarded two points if a second more specific 
prompt was required, one point if after prompting, the required action was completed on the 
second attempt and no point if the participant failed to complete the required action after 
prompting. Total scores were then generated on time-based and event based subscales, each 
scoring a maximum of 18, with higher scores reflecting better prospective memory 
performance. The validity and reliability of the CAMPROMPT has been documented in a 
number of studies (i.e., Fleming et al., 2008; Groot et al., 2002; Wilson et al., 2005).  
 
Procedure 
Participants were informed of the purpose of the investigation and their right to 
withdraw at any time. After consent had been obtained the tests were administered under 
laboratory conditions. The drug-use questionnaire (Montgomery et al., 2005) was 
administered first followed by the Raven’s progressive matrices (Raven et al., 1998), the 
age/education questionnaire, the PRMQ (Crawford et al., 2005), the MCQ (Dixon de Frias, & 
Bäckman, 2001) and the BRIEF-A (Roth et al., 2005) questionnaires. Finally, the RAVLT 
and the CAMPROMPT (Wilson et al., 2005) tests were administered. Participants were fully 
debriefed, paid £20 in Tesco store vouchers and given drug education leaflets. The University 
of Central Lancashire’s ethics committee approved the study. Data for the BRIEF-A obtained 
in the present study have been included with similar data that were collected previously by us 
from another group of participants and are the subject of a separate publication 
(Hadjiefthyvoulou et al., 2010). Participants also performed a range of other tasks that are 
beyond the scope of the present investigation. 
Results 
 As is apparent from inspection of Table 1, with the exception of tobacco smoking the 
groups did not differ significantly on any of the background variables. The proportion of 
smokers differed significantly between the groups, χ2 (N=53, df=2) = 8.09, p=.017, however, 
the expected frequency in one of the cells, 3.94, was below the critical value of 5 thus 
although there are clear differences between the groups with 40-50% of illicit drug users 
regularly smoking and only 1 nonuser, the statistical significance of this outcome cannot be 
confirmed by chi-squared. The daily consumption of cigarettes did not differ significantly 
between ecstasy/polydrug and cannabis only users, t (16) = 0.75, p>.05. Indicators of illicit 
drug use may be found in Table 2. It is clear that the ecstasy/polydrug group used a range of 
other illicit substances in addition to ecstasy, including cannabis, cocaine, and ketamine. 
Furthermore, for all of the measures of drug use, the median was substantially less than the 
mean, indeed in all cases the measures exhibited a positive skew, with a small minority of 
users demonstrating relatively high levels of use while the majority were clustered around the 
median. Members of both illicit drug using groups had also used poppers (amyl nitrate) 
during the preceding three months (as had one individual among the non illicit drug users). It 
is worthy of note that the various indicators of cannabis use did not differ significantly 
between the two illicit drug using groups. 
 Data screening revealed that there were no univariate outliers on the PM scores. 
However the distribution of the event-based PM measure deviated significantly from normal 
exhibiting a negative skew. Following the data transformation procedure recommended by 
Tabachnick and Fidell (2007) the event based scores were reflected and the square root was 
taken. This means that trends in the transformed variable are reversed so that higher scores 
are indicative of worse performance. Subsequent tests revealed that the distribution of the 
transformed variable did not deviate significantly from normal. Table 3 contains both the 
untransformed and the transformed event based PM measure. However the analyses reported 
below relate to the latter. 
Inspection of Table 3 reveals that compared to the other two groups non illicit drug 
users displayed better PM performance on both the time and event based measures. The 
ecstasy/polydrug users’ scores were the worst while cannabis only users’ scores were 
between those of the other two groups. These trends were associated with statistically 
significant overall group differences. Subsequent post hoc tests revealed that with respect to 
the event-based PM measure, ecstasy/polydrug users performed significantly worse than the 
other two groups which in turn did not differ significantly from each other. The only 
statistically significant pairwise difference on the time-based PM measure was with respect to 
the ecstasy/polydrug group which performed significantly worse than the non illicit drug 
users group. 
With regard to the BRIEF-A, the MCQ, and the RAVLT measures, two univariate 
outliers were identified, one on the decay score of the RAVLT and the other on the change 
score of the MCQ. These were replaced by the next highest/lowest score on the particular 
measure, plus/minus one (Tabachnick & Fidell, 2007). On the basis of Mahalanobis distance 
no multivariate outliers were detected. Examination of Table 3 reveals that there were 
statistically significant group differences on only two of the non PM measures. First, the 
groups differed significantly on Crawford et al.’s (2005) self-report retrospective memory 
measure, with ecstasy/polydrug users scoring significantly worse than non illicit drug users 
(neither of the other pairwise comparisons were statistically significant). Second, non illicit 
drug users made significantly more use of external memory aids compared to 
ecstasy/polydrug users. The difference between the non users and cannabis-only users on the 
same measure approached significance. 
For the sample as a whole, correlations between the PM and the other measures are 
set out in Table 4. The event based PM measure was significantly correlated with the time 
based measure (as might be expected). It was also significantly correlated with two of the 
retrospective memory measures: the Crawford et al. (2005) self-report measure and the recall 
score on the RAVLT over trials 1-5. Unsurprisingly, better retrospective memory 
performance was associated with better PM performance (High scores on the Crawford et al. 
measure are indicative of retrospective memory problems while the reverse is true of the time 
based and untransformed event based PM measures. Hence the correlation with the Crawford 
et al measure is negative in the former case and positive in relation to the transformed event 
based PM measure.) The correlation between the ‘Reliance’ subscale on the MCQ and the 
event based PM measure approached statistical significance: as reliance on others as an aid to 
memory increased, so PM performance decreased. Interestingly the event based PM measure 
was not significantly correlated with either of the BRIEF-A composite scales. The time based 
PM measure, like the event based, was significantly correlated with the Crawford et al. 
(2005) self-report retrospective memory measure, and with the recall score on the RAVLT 
over trials 1-5 the correlation approached significance; in both cases better retrospective 
memory was associated with better time-based PM performance. The correlation between the 
time based PM measure and the BRIEF-A metacognitive index also approached statistical 
significance. Higher executive functioning was associated with better time based PM 
performance. 
In order to evaluate the unique contributions of each of the predictors to PM 
performance, two regressions were run with respectively the transformed event based PM 
measure and the time based PM measure as dependent variables. Variables were included as 
predictors if they were significantly correlated (in bivariate terms) with the dependent 
variable or if they were associated with significant group differences on the dependent 
measure. In instances where the univariate or bivariate outcomes approached statistical 
significance, the variables in question were also included as predictors. The results for the 
regression analyses are set out in the penultimate two columns of Table 4. None of the 
individual predictors for time based PM were statistically significant, however, the overall 
model accounted for statistically significant variance (r
2
 = .285, p<.05). The likely 
implication of this is that there was a degree of overlapping variance with pairs or larger 
combinations of predictors sharing pooled variance with the dependent variable making it 
impossible to allocate statistically significant unique variance to any one predictor. More 
specifically, it is possible that the statistically significant drug-related PM effects apparent in 
the ANOVA are in part mediated by drug-related differences on the other predictors, in 
particular, aspects of retrospective memory. 
Switching the focus to event based PM, the regression model accounted for 
statistically significant variance, (r
2
 = .378, p<.01). Of the individual predictors, the recall 
score on the RAVLT over trials 1-5 approached statistical significance, unsurprisingly better 
recall was associated with better PM performance. Of the other predictors, ecstasy/polydrug  
users (relative to other participants) accounted for statistically significant unique variance 
(reflecting the ecstasy/polydrug-related PM deficit). Thus it appears that the ecstasy/polydrug 
effect on event based PM cannot be entirely attributed to drug-related differences in 
retrospective memory and executive functioning. Surprisingly the dichotomous gender 
variable was also statistically significant as a predictor. Given the manner in which the 
variable was coded and the sign of the beta weight, this would suggest that females were 
performing worse than males on the event based PM task. Paradoxically, a subsequent t test 
revealed no statistically significant gender difference on the event based PM task, t (57) = 
0.13, p>.05. However, further examination of the gender differences within the drug using 
groups showed that the gender deficit was only apparent among ecstasy/polydrug users. 
Among other participants, females were actually performing better. This raised the possibility 
of an interaction between gender and ecstasy/polydrug use in determining event based PM 
scores. In order to test this possibility the regression was repeated, this time, in addition to the 
ecstasy/polydrug and gender variables, their product was included as an independent variable 
in order establish whether or not there was a statistically significant interaction. The results 
are set out in the final column of Table 4, inspection of which reveals that in this expanded 
model only the interaction between gender and ecstasy/polydrug use accounts for statistically 
significant unique variance. Given the manner in which the dichotomous variables were 
coded, the positive beta coefficient indicates that female ecstasy/polydrug users were 
especially impaired on the event based CAMPROMPT task. By way of clarification 
subsequent analyses revealed that the mean scores for female ecstasy/polydrug users was 
65% higher than that for female non ecstasy users, while the equivalent difference for males 
was just 16% (as noted above higher scores are indicative of poorer event based PM 
performance).  
The incidence of polydrug use among the ecstasy users makes it difficult to 
unambiguously attribute the impairments evident in PM to specific illicit drugs. In an attempt 
to address this issue Table 5 contains the simple and partial correlation coefficients between 
aspects of drug use on the one hand and the two PM measures on the other. Where an 
individual does not use a specific drug there usage has been coded as zero. Inspection of the 
Table reveals that only one aspect of drug use is correlated with time based PM, i.e., the 
current frequency of cannabis use. In view of this outcome no partial correlations were 
calculated for time based PM. By way of contrast, virtually all aspects of drug use were 
correlated with event based PM. However, when controls for the use of other illicit drugs 
were entered, aspects of ecstasy use were no longer significantly correlated with event based 
PM, rather it was aspects of cannabis and cocaine use which yielded statistically significant 
correlations. 
The illicit drug users among our sample were requested to refrain from cannabis use 
for 24 hours prior to testing and from cocaine, ecstasy, and other drug use for 7 days prior to 
testing. In order to address the possibility that the PM differences that we observed were due 
to post intoxication effects we excluded all individuals who indicated that they had consumed 
ecstasy, cocaine, or cannabis during the 10 days prior to testing. This reduced the size of the 
cannabis-only group thereby reducing statistical power such that three-way group 
comparisons were not meaningful. For this reason the non illicit drug users and cannabis only 
users were merged to form a single group (drug naive/cannabis only n=25; ecstasy/polydrug 
n=14) . For the event based PM task the corresponding means (standard deviations) for the 
ecstasy/polydrug and combined drug naive/cannabis only users were respectively 2.20 (0.73) 
and 1.69 (0.47) which differenced significantly, F(1,37) = 7.10, p<.05. For the time based PM 
task the equivalent figures were respectively 10.92 (3.65) and 14.40 (4.65) which again 
differenced significantly, F(1,37) = 5.78, p<.05. Thus the ecstasy/polydrug related PM 
deficits remained statistically significant following removal of those persons who indicated 
that they had used illicit drugs during the previous 10 days. 
Discussion 
On the event based PM measure ecstasy/polydrug users were impaired relative to both 
cannabis only and non users of illicit drugs. This group was also impaired relative to nonusers 
on the time based measure. While a trend was evident on both measures with 
ecstasy/polydrug users performing worse, cannabis only users achieving intermediate levels 
of performance and non illicit drug users performing best, cannabis only users did not differ 
significantly from non users of illicit drugs on either PM measure. The ecstasy/polydrug-
related deficit observed here in relation to non illicit drug users is consistent with previous 
findings from our own and other laboratories using self report (Hadjiefthyvoulou et al., in 
press; Heffernan et al., 2001a; 2001b; Montgomery & Fisk, 2007; Rodgers et al., 2001; 2003) 
and laboratory measures (Hadjiefthyvoulou et al., in press; Rendell et al., 2007a). They also 
demonstrate the utility of the CAMPROMPT measure in detecting individual differences in 
PM performance among non clinical populations augmenting the existing literature in this 
regard (Groot et al., 2002; Wilson et al., 2005). 
For the most part ecstasy/polydrug deficits were not evident on the other measures 
that were administered. Deficits were only evident on the retrospective memory questionnaire 
and non users of illicit drugs were significantly more likely to report using external memory 
aids in everyday contexts. Cannabis-only users did not differ significantly from either of the 
other two groups on any of the non PM measures. 
For the sample as a whole, individual differences on both PM measures were 
significantly correlated with outcomes on the retrospective memory questionnaire and with 
the RAVLT recall scores for the first five trials. In both cases better retrospective memory 
was associated with better PM performance. Scores on the BRIEF-A metacognitive index 
were also related to performance on the time based PM task with better executive functioning 
associated with improved PM performance, however, this trend only approached statistical 
significance two tailed (although given the directional nature of the anticipated effect, the 
outcome is statistically significant on a one-tailed basis). These findings are consistent with 
the outcomes reported above linking PM performance with medial temporal functioning 
(Adda et al., 2008; Martin et al., 2007) and with PFC processes (e.g., Okuda et al., 2007). 
In order to establish the extent to which drug related deficits on the PM tasks were 
mediated by deficits in retrospective memory and executive functions, regressions were run 
with each of the PM variables as the criterion. For the time based PM task the dummy 
variable representing the effects of ecstasy/polydrug use was not statistically significant as a 
predictor. Indeed although the model as a whole accounted for statistically significant 
variance, none of the individual predictors were statistically significant. This suggests that 
any effects associated with ecstasy/polydrug use covary with individual differences in the 
other predictors and with the criterion leaving open the question of whether drug use per se 
adversely affects time based PM.  
The regression analysis for event based PM yielded different results with only 
ecstasy/polydrug use and gender accounting for statistically significant unique variance. A 
further regression revealed that the two predictors in fact significantly interacted such that the 
ecstasy/polydrug related deficit was most pronounced amongst female users. Indeed neither 
of the main effects were statistically significant in the amended model. Of the other 
predictors in the model, the RAVLT recall scores for the first five trials approached statistical 
significance. It is noteworthy that the sum of the squared semi-partial correlation coefficients 
(.139) is far less than the overall R squared value (.431), indicating that most of the explained 
variance in the criterion reflects the overlapping effects of two or more predictors.  
The emergence of gender specific illicit drug-related effects is not without precedent. 
For example, women who were heavy users of cannabis were impaired relative to female 
light users on visuo-spatial memory, while no such deficit emerged among male cannabis 
users (Pope et al., 1997). Gender was also found to moderate the extent of ecstasy-related 
deficits in design fluency (with female users exhibiting a deficit while male users actually 
performed better than controls) although it was not a moderating factor on deficits observed 
in verbal learning (Medina et al., 2005). Reneman et al. (2001) found that female ecstasy 
users exhibited a larger reduction in serotonin transporter densities relative to males. 
However, in a subsequent study in which ecstasy users were found to be impaired in various 
aspects of memory performance, female users were not significantly more affected than male 
users (Reneman et al., 2006). It is also worthy of note that the gender-drug use interaction 
only emerged on event based PM tasks and not on the time based PM measure. Thus the 
apparent gender difference observed in the present study should be treated with a degree of 
caution. 
While deficits in aspects of PM are clearly evident among ecstasy/polydrug users, 
what is less clear is which illicit drug or drugs may be responsible for these deficits. It is 
striking that when the use of other drugs is controlled through partial correlation, no aspect of 
ecstasy use is statistically significant as a predictor of PM performance. It is also worthy of 
note that while cannabis-only users were not significantly impaired relative to non illicit drug 
users, they did performance worse on both PM measures compared with controls and 
cannabis use among the whole sample was significantly correlated with event based PM even 
following statistical controls for the effects of other illicit drugs. Higher levels of 
consumption during the previous 30 days and increasing frequency of use were associated 
with poorer event based PM performance. Thus the present results suggest that cannabis use 
does adversely affect PM performance although the effect may be accentuated among 
polydrug users. The present results augment those of other studies in which cannabis-related 
PM deficits have been observed, (e.g., Fisk & Montgomery,2008; McHale & Hunt, 2008; 
Rodgers et al., 2003). 
A striking feature of the present results was that cocaine use was significantly 
correlated with event based PM performance even following statistical controls for the use of 
other illicit drugs. Increasing lifetime dose, greater consumption during the previous 30 days 
and an increased frequency of use are all associated with poorer event based PM 
performance. This replicates the results of our previous study (Hadjiefthyvoulou et al., in 
press), this time, with a different sample and with an alternative laboratory based PM 
measure.   As far as we are aware, the present study and our previous one are the first to link 
the recreational use of cocaine with prospective memory deficits. The mechanisms through 
which cocaine might adversely affect PM functions remain unclear. On the basis of the 
results from their fMRI study, Tomasi et al. (2007) argue that a prior history of cocaine use 
disrupts the operation of those dopaminergic systems in the prefrontal cortex which underpin 
executive functioning. Given the key role of executive functions in supporting PM processes 
this might account for the adverse association between cocaine use and PM functioning. 
It is also noteworthy that PM deficits have been observed in Parkinson’s patients 
(Kliegel et al., 2005) and since the disease is characterised by disruption of dopaminergic 
functioning in the cortico-striatal pathway, this is consistent with a direct role for dopamine 
in supporting PM functions. Evidence consistent with this proposition emerged in a recent 
study by Costa et al (2008) in which administration of L-dopa significantly improved PM 
performance in a sample of Parkinson’s patients relative to an unmedicated condition. As 
noted above, animal studies have also suggested a direct role for mesocortical dopaminergic 
systems in supporting prospective memory processes (Goto & Grace, 2008). Since it is 
known that both cocaine and ecstasy potentially disrupt the functioning of dopaminergic 
systems, it is possible that the basis of the prospective memory deficits observed in the 
present study reside in impaired dopaminergic processes in the cortico-striatal pathway.   
A further possibility is that cocaine might give rise to impairment in medial temporal 
and hippocampal processes. In a recent study, Fox et al. (2009) found that performance on 
various aspects of the RAVLT was impaired among an inpatient cocaine dependent group. 
Relative to controls, deficits were related to self report stress levels and within the cocaine 
dependent group with raised early morning cortisol levels. Fox et al. attribute the stress-
related increase in cortisol levels and the associated memory deficits to hippocampal damage 
stemming from cocaine use. If this were the case, in the present context the recall component 
of PM performance might be compromised among recreational cocaine users thereby 
accounting for the results obtained here. 
A number of limitations can be identified for this study. First, as with many studies in 
this area no objective measure of recent drug use such as urinalysis or hair analysis was used. 
Thus the period of abstinence cannot be objectively verified. Also, the purity of the ecstasy 
tablets or any other consumed drug cannot be guaranteed making it still more difficult to 
attribute the effects observed here to specific psychoactive drugs. Another important factor 
that should not be overlooked is that the apparent ecstasy/polydrug related deficits may not 
necessarily be a consequence of illicit drug use but instead be due to pre-existing differences 
between users and non users originating before the onset of illicit drug use. In addition, the 
possibility that current lifestyle differences or the effects of illicit drug use on other 
physiological processes (e.g., impaired sleep quality) might be the actual cause of the deficits 
observed in the current study cannot be entirely excluded. A methodological issue that needs 
to be considered is the relatively small sample size in the present study which means that the 
results of the regression analyses need to be treated with caution. Indeed, before definitive 
statements can be made regarding the relative importance of individual predictors, the 
regression analysis would need to be replicated with a substantially larger sample. 
Nonetheless, the present results are potentially informative as a guide for which variables 
might be incorporated into future research utilising larger samples. Other methodological 
aspects of the present study might warrant a different approach in future research. For 
example, we used a self report measure of executive functioning rather than laboratory based 
measures.  It might have been desirable to incorporate laboratory based tests of executive 
functioning, however, recent conceptualisations of executive functioning  have emphasised 
the non unitary nature of these processes, identifying four or more separable processes: 
updating, inhibition, switching, and access to semantic memory (Fisk & Sharp, 2004; Miyake 
et al, 2000) each with a number of specific measures. Furthermore, ecstasy/polydrug users 
appear to be differentially affected on each of these (Montgomery et al., 2005). Thus the 
inclusion of such a comprehensive test battery would have substantially expanded the length 
of the test session and was not possible given the resource constraints of the present study. 
Nonetheless future research might incorporate such measures, perhaps utilising latent 
variable analysis in order to evaluate the potential role of the various executive component 
processes with respect to a range of different PM measures. 
To conclude, the present study intended to determine the impact of ecstasy/polydrug 
use and cannabis use on event based and time based prospective memory using the 
CAMPROMPT. Measures of executive functioning and retrospective memory were also 
administered in order to study the extent to which executive processes account for the 
prospective memory deficits in recreational drug users. Relative to both drug naive persons 
and cannabis only users, ecstasy/polydrug users performed significantly worse on both event 
based and time based prospective memory tasks while no significant differences in 
performance were observed between the cannabis user and non user groups. However, 
consistent with the results of our previous study, recreational use of cocaine was significantly 
correlated with event based prospective memory performance, demonstrating the need for a 
systematic investigation of the potential role of cocaine in accounting for the PM deficits that 
have been observed here and in other studies.  
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 Table 1 Age, intelligence, years of education, cigarette and alcohol use by group. 
 
 
 
Ecstasy/Polydrug 
Users 
Cannabis-Only Users Nonusers  p
1
 
 Mean S.D. n Mean S.D. n Mean S.D. n  
           
Age (years) 21.17 1.79 29 21.92 1.56 12 20.44 2.28 18 ns 
Ravens Progressive 
Matrices (maximum 60) 
39.21 8.39 29 40.25 7.35 12 40.72 8.90 18 ns 
Years of Education 15.27 2.44 26 14.92 4.06 12 16.00 2.00 18 ns 
           
Cigarettes per day 7.42 4.48 12 9.00 3.58 6 15.00 - 1 .017 
Alcohol (Units per 
week) 
13.41 12.08 27 15.18 12.95 11 9.47 14.70 15 ns 
           
 
1. For one-way ANOVA except cigarettes where χ2 test was used. 
 
 
 
 Table 2. Indicators of Illicit Drug Use 
 
 
 
Ecstasy/Polydrug Users Cannabis-Only Users p
1
 
 Median Mean S.D. n Median Mean S.D. n  
          
Total Use          
   Ecstasy (Tablets) 194 640.86 1284.99 29 - - - - - 
   Cannabis (joints) 728 3048.84 5297.53 25 1118 2242.58 3307.71 12 ns  
   Cocaine (lines) 416 1037.89 1282.60 19  - - - - 
          
Amount Consumed 
in Previous 30 Days 
         
   Ecstasy (Tablets) 0 3.14 8.28 29 - - - - - 
   Cannabis (joints) 1 26.08 45.80 25 0.50 22.25 33.05 12 ns  
   Cocaine (lines) 2 8.16 12.74 19 - - - - - 
          
Frequency of Use 
(times per week) 
         
   Ecstasy 0.04 0.24 0.43 29 - - - - - 
   Cannabis 0.25 1.87 2.52 25 0.15 1.86 2.71 12 ns 
   Cocaine 0.06 0.28 0.36 19 - - - - - 
          
Weeks Since Last 
Use: 
         
   Ecstasy 12 47.00 76.32 29 - - - - - 
   Cannabis 4 20.34 37.13 25 7.50 73.32 113.69 12 ns 
   Cocaine 6 15.40 24.36 22 - - - - - 
          
Use of Other Drugs 
during the Previous 
3 Months 
Percent    Percent     
Amphetamine 3    0     
Ketamine 31    8     
LSD 3    0     
Magic Mushrooms 3    0     
Poppers 45    17     
          
 
1. For Mann-Whitney U 
 
 
Table 3. Outcomes for the Prospective Memory, Executive Functions, and Memory Measures by Group. 
***, p<.001; ** p<.01; * p<.05. 
1. Only statistically significant differences or differences approaching statistical significance are reported. 
2. This is the transformed variable where higher scores are indicative of worse performance. 
 Ecstasy/Polydrug 
Users 
 Cannabis-Only Users  Nonusers  F Pairwise Comparisons 
(Tukey’s test)1 
 Mean S.D. n Mean S.D. n Mean S.D. n  E/PU 
vs  
CO 
E/PU 
vs. 
Non 
CO 
vs. 
Non 
CAMPROMPT              
Event Based PM 12.48 3.27 29 15.08 2.39 12 16.00 1.68 18     na    
Event-Based PM
2
 2.46 0.69 29 1.90 0.59 12 1.66 0.50 18 10.10*** .027 .000   
Time-Based PM 10.45 3.94 29 12.33 5.65 12 15.11 3.51 18   6.79**  .001  
BRIEF              
Behaviour Regulation 54.50 10.83 24 48.91 11.79 11 50.43 7.57 14   1.38    
Metacognition 73.96 13.59 24 70.55 12.30 11 65.69 15.82 16   1.66    
Retrospective Memory 
Questionnaire 
21.63 7.09 27 19.83 5.77 12 16.65 4.33 17   3.48*  .029  
MCQ              
External 25.18 7.61 28 24.25 9.30 12 30.67 4.84 18   3.96*  .041 .055 
Internal 31.32 5.98 28 29.25 6.84 12 33.17 7.88 18   1.21    
Time 14.18 3.39 28 12.67 4.64 12 15.11 3.86 18   1.48    
Reliance 14.79 4.28 28 15.25 4.20 12 13.22 4.86 18   0.95    
Effort 20.61 4.01 28 20.67 3.87 12 21.33 4.19 18   0.19    
Success 14.04 3.29 28 12.83 3.95 12 13.18 3.91 17   0.58    
Change 19.93 3.89 28 21.50 3.45 12 20.33 4.51 18   0.64    
RAVLT              
Learning T1-T5 39.04 9.38 28 40.58 11.11 12 45.22 9.60 18   2.21    
Proactive 0.89 1.77 28 1.58 1.38 12 0.94 1.47 18   0.83    
Retroactive 1.57 2.41 28 2.00 1.86 12 1.39 1.46 18   0.33    
Decay 2.00 2.17 27 2.00 1.76 12 1.22 1.26 18   1.10    
Table 4  
The Relationship between Time and Event Based PM and Executive and Memory Functions 
 
***, p<.001; ** p<.01; * p<.05; † p<.10. 
1. This is the transformed variable where higher scores are indicative of worse 
performance. 
 
 
Correlate/IV Simple Correlation Standardised beta weight and (squared semi-
partial correlation from regression) 
 
 Event- 
Based 
PM
1
 
Time-
Based PM  
DV = Event- 
Based PM
1
 
DV = Time-
Based PM  
DV = Event- 
Based PM
1
 
CAMPROMPT      
Event-Based PM
1
  -.523***    
Time-Based PM -.523***     
BRIEF      
Behaviour Regulation .184 -.105    
Metacognition .130 -.248
†
  .034 (.001)  
Retrospective Memory 
Questionnaire 
.270* -.381** .019 (.000) -.361 (.038) -.026 (.000) 
MCQ      
External -.075 .052 -.172 (.014) .097 (.003) -.154 (.012) 
Internal -.003 .007    
Time -.084 -.068    
Reliance .258
†
 -.184 .180 (.021)  .194 (.024) 
Effort -.193 -.064    
Success .019 .008    
Change .035 -.021    
RAVLT      
Learning T1-T5 -.273* .244
†
 -.239 (.051)
†
 .217 (.040) -.208 (.038)
†
 
Proactive .008 -.042    
Retroactive .095 .033    
Decay .152 -.060    
      
Gender   .314 (.060)* -.090 (.004) .012 (.000) 
      
Ecstasy/polydrug versus all 
others 
  .555 (.138)** -.277 (.034) .218 (.011) 
Ecstasy/polydrug versus all 
others by Gender interaction 
  - - .423 (.053)* 
Cannabis-only versus all 
others 
  .095 (.005) -.130 (.009) .037 (.001) 
   r
2
 = .378 r
2
 = .285 r
2
 = .431 
   F(7,47)=4.09, 
p<.01 
F(7,41)=2.34, 
p<.05 
F(8,46)=4.36, 
p<.001 
Table 5 
The Relationship between Time and Event Based PM and Indicators of Illicit Drug Use 
 
 
 
 
 
 
 
 
 
 
 
 ***, p<.001; ** p<.01; * p<.05; one tailed. 
1. Correlation for the transformed variable. 
2. Controlling for the use of other drugs on the measure in question, e.g., the correlation 
between total use of cannabis and PM controlling for the total use of cocaine and total 
use of ecstasy. 
 
 
 
 Event- 
Based PM
1
 
Time 
Based PM 
 Simple 
Correlation 
Partial  
Correlation
2
 
Simple 
Correlation 
Cannabis    
Total Lifetime Use .246* .208 -.154 
Consumed in last 30 days .259* .230* -.158 
Frequency .338** .390** -.286* 
    
Cocaine    
Total Lifetime Use .339** .328** -.139 
Consumed in last 30 days .257* .261* -.126 
Frequency .403** .416*** -.133 
     
Ecstasy    
Total Lifetime Use .261* -.002 -.160 
Consumed in last 30 days .210 -.036 -.058 
Frequency .268* -.028 -.065 
    
